UBFO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
UBFO is not a good buy right now for an impatient investor. The technical trend is bullish, but the stock is already near resistance with RSI pushing the high end of neutral, there are no Intellectia buy signals today, options data is effectively illiquid, and near-term pattern stats lean slightly negative over the next day/week. The M&A-related news may cap upside to deal terms, making the risk/reward less attractive for an immediate entry.
Trend is bullish: moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200), suggesting sustained upward momentum. MACD histogram is positive (0.0275) and expanding, confirming bullish acceleration. RSI(6) is 68.09 (upper-neutral, close to overbought), implying the stock may be stretched short-term. Key levels: Pivot 10.593; support S1 10.26 (then S2 10.055). Resistance R1 10.925 (then R2 11.13). With price ~10.74 post-market, it’s closer to resistance than support, reducing immediate upside for a quick entry. Pattern-based expectation provided: ~40% chance of -1.08% next day, -0.79% next week, +3.07% next month—near-term skew slightly negative.
Insider activity: insiders are buying, with the buying amount up ~2339.95% over the last month—generally supportive for confidence in value/outlook.
Technical momentum remains positive (bullish MA stack + positive/expanding MACD).
Corporate action backdrop: news references UBFO being sold to Community West Bancshares, which can support price stability into deal processes (depending on terms and closing probability).
Near-term entry is less favorable: RSI near overbought and price is approaching resistance (R1 10.925), increasing odds of a pause/pullback.
No Intellectia proprietary buy signals today (AI Stock Picker: none; SwingMax: none), reducing conviction for an immediate buy.
Options are illiquid (no volume), limiting confirmation of bullish sentiment and making hedging/pricing signals noisy.
Event-driven uncertainty: the legal/rights-related news (Halper Sadeh LLC investigation/announcements) around the UBFO sale can create headline risk and can also imply upside is capped by deal economics.
Latest reported quarter: 2025/Q3. Revenue rose to 13,401,000 (+3.99% YoY), net income increased to 4,023,000 (+5.07% YoY), and EPS increased to 0.23 (+4.55% YoY). Overall, steady positive growth across the key lines; no margin detail beyond a reported gross margin figure of 0 (not informative for a bank-style income statement).
No analyst rating trend or price-target change data was provided, so there’s no clear Wall Street consensus signal to lean on. With the available information, the ‘pros’ case is insider buying + steady Q3 growth + bullish technicals; the ‘cons’ case is lack of fresh analyst support, no proprietary buy signal, near-resistance technical setup, and M&A/event-driven upside potentially capped by transaction terms. Other flows: Hedge funds are reported neutral. Politician/congress activity: no recent congress trading data available, and no politician/influential-figure transactions were provided.
